Pay in 4 interest-free payments of $5.47 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Retatrutide (Future Option) Projected cost: likely $400-$700/month when available Triple-agonist retatrutide awaits FDA approval expected in 2026-2027
All three drugs share the same common active ingredient: semaglutide
This formulation utilizes three ways to support glutathioneintracellular with SAG, intracellular biosynthesis with NAC, and extra/intracellular (systemic) support with GSH.* Moreover, this formula provides a double layer of protection for the glutathione molecule (SAG), with acetylation and liposomes, to further support intracellular bioavailability.* Features Gives the body three ways to increase and optimize glutathione levels* Gluten-free and dairy-free, as confirmed by testing Liposomes are composed of non-hydrogenated phospholipids, derived from GMO-free sunflower lecithin Benefits Supports intracellular and mitochondrial antioxidant processes* Supports healthy brain function* Supports the liver and detoxification activity* Supports balanced immune system function* Suggested Use: Take 5 mL (approx
Frequently Asked Questions Based on the current timeline, retatrutide FDA approval is expected between Q3 2027 (if priority review is granted) and Q1Q2 2028 (under standard review)
Vitamins, minerals and nutrients such as carotenoids, vitamin A and C, selenium, bioflavonoids and glutathione act as antioxidants
Most people with type 2 diabetes take medications to manage their blood sugar and reduce their risk of diabetes-related complications, such as heart disease
